Black and white patients within the same health system are subject to very different opioid prescribing behaviors, a new study published in the New England Journal of Medicine points out.

Leonard L. Edloe, PharmD, ThM, will be installed as the Virginia Pharmacists Association’s (VPhA) first Black president-elect during the organization’s 140th Annual Convention. It’s one more remarkable achievement for a pharmacist who’s been showered with high-profile appointments and professional accolades over his 50-year career—but this one carries particular significance. Decades ago, VPhA denied membership to Edloe’s father based on the color of his skin.

According to a new survey from the Alliance for Safe Online Pharmacies (ASOP) Global Foundation, almost half of Americans gamble with their lives to buy medication from online sources—even though the overwhelming majority of them operate illegally. That’s just one of the alarming findings from the organization’s 2021 survey of American perceptions and use of online pharmacies, which was commissioned from Abacus Data.

After Pfizer announced in late June that it was halting worldwide distribution of varenicline (Chantix) after detecting elevated levels of nitrosamines in the drug, FDA came out to alert patients and health professionals about the voluntary recall.

Have we made any progress in improving racial health inequities since the early 2000s? Researchers at Harvard Medical School, who published their findings in the Journal of the American College of Cardiology, wanted to find out.